Acta Neurologica Scandinavica

Article	Citations
Neurological side effects of SARS‐CoV‐2 vaccinations	112
The potential neurological effect of the COVID‐19 vaccines: A review	82
Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta‐analysis	42
Parkinson’s disease and intensive exercise therapy — An updated systematic review and meta‐analysis	41
Glymphatic dysfunction in isolated REM sleep behavior disorder	40
Neutrophil–lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis	39
COVID‐19 presentations and outcome in patients with epilepsy	35
Blood biomarkers for Alzheimer's disease and related disorders	33
Blood biomarkers in ALS : challenges, applications and novel frontiers	33
Refractory migraine profile in CGRP‐monoclonal antibodies scenario	31
Neutrophil‐to‐lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review	29
Microglia and immunotherapy in Alzheimer’s disease	27
Systolic blood pressure variability following endovascular thrombectomy and clinical outcome in acute ischemic stroke: A meta‐analysis	26
Persistent olfactory dysfunction after COVID‐19 is associated with reduced perfusion in the frontal lobe	26
SARS‐CoV‐2 vaccines are not free of neurological side effects	25
Vagus nerve stimulation in patients with Lennox‐Gastaut syndrome: A meta‐analysis	25
Telehealth approach for amyotrophic lateral sclerosis patients: the experience during COVID‐19 pandemic	24
Blood biomarkers of peripheral neuropathy	23
Effectiveness of clinical exome sequencing in adult patients with difficult‐to‐diagnose neurological disorders	23
Potassium channels and epilepsy	23
Multiple cranial nerve palsies following COVID‐19 vaccination—Case report	23
Multiple sclerosis and COVID‐19: The Swedish experience	22
Blood biomarkers in epilepsy	20
Socioeconomic consequences of multiple sclerosis—A systematic literature review	19
Identification of novel signal of clobazam‐associated drug reaction with eosinophilia and systemic symptoms syndrome: A disproportionality analysis	19

Guillain‐Barre syndrome following COVID‐19 vaccines: A scoping review	19
Supervised exercises versus telerehabilitation. Benefits for persons with multiple sclerosis	19
Non‐pharmacological therapies for pain management in Parkinson's disease: A systematic review	19
People with epilepsy still feel stigmatized	19
Accuracy of NIH Stroke Scale for diagnosing aphasia	18
Leukoaraiosis severity and post‐reperfusion outcomes in acute ischaemic stroke: A meta‐analysis	18
Large hemorrhagic stroke after ChAdOx1 nCoV‐19 vaccination: A case report	18
Neurological manifestations as primary presentation of COVID‐19 in hospitalized patients	18
Aquatic therapy in stroke rehabilitation: systematic review and meta‐analysis	17
Neurological symptoms and blood neurofilament light levels	17
Epilepsy and lockdown: A survey of patients normally attending a Spanish centre	17
Quality of life in patients with glioblastoma and their relatives	17
Risk factors for minor hallucinations in Parkinson's disease	17
Parkinson’s disease in Sweden—resource use and costs by severity	17
Myasthenia gravis and COVID‐19: A case series and comparison with literature	17
Efficacy of high‐intensity aerobic exercise on common multiple sclerosis symptoms	16
CTP‐guided reperfusion therapy in acute ischemic stroke: a meta‐analysis	16
In‐hospital systems interventions in acute stroke reperfusion therapy: a meta‐analysis	15
Efficacy of lacosamide and phenytoin in status epilepticus: A systematic review	15
Small fiber neuropathy	15
Mechanical thrombectomy with or without thrombolysis: A meta‐analysis of RCTs	14
Early identification of epilepsy surgery candidates: A multicenter, machine learning study	14
Effects of subthalamic deep brain stimulation on non‐motor symptoms of Parkinson's disease: A meta‐analysis	14
Impact of comorbidities on the disability progression in multiple sclerosis	14
Standardized mortality ratios in multiple sclerosis: Systematic review with meta‐analysis	14
Brain networks in migraine with and without aura: An exploratory arterial spin labeling MRI study	14
Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis	14
Temporal lobe epilepsy with amygdala enlargement: A systematic review	13
Machine learning analysis of heart rate variability to detect delayed cerebral ischemia in subarachnoid hemorrhage	13
Myelin‐associated oligodendrocyte basic protein rs616147 polymorphism as a risk factor for Parkinson's disease	13
Quality of life long after temporal lobe epilepsy surgery	13
Medium‐term effects of COVID‐19 pandemic on epilepsy: A follow‐up study	12
Ketamine in adult super‐refractory status epilepticus: Efficacy analysis on a prospective registry	12
Neuromodulation in drug‐resistant epilepsy: A review of current knowledge	12
Prehospital recognition of stroke is associated with a lower risk of death	12
Comorbidities in older patients with myasthenia gravis — Comparison between early‐ and late‐onset disease	12
Medical complications and outcome after endovascular therapy for acute ischemic stroke	12
Meta‐analysis of association between migraine and risk of dementia	12
Neurofunctional outcomes in patients with anti‐leucine‐rich glioma inactivated 1 encephalitis	12
Bone health, intellectual disability and epilepsy: An observational community‐based study	12
Motor Band Sign in Motor Neuron Diseases Using Magnetic Resonance Imaging: A Systematic Review	12
Seizure outcome trajectories in a well‐defined cohort of newly diagnosed juvenile myoclonic epilepsy patients	11
Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus narcolepsy	11
Blood based biomarkers for movement disorders	11
Fatigue 7 years post‐stroke: Predictors and correlated features	11
Pregnancy and neurologic complications of COVID‐19: A scoping review	11
Blood‐based biomarkers and traumatic brain injury—A clinical perspective	11
Advances in sudden unexpected death in epilepsy	11
Diversified social cognition in temporal lobe epilepsy	11
Dynamic gray matter and intrinsic activity changes after epilepsy surgery	11

Therapy delay in status epilepticus extends its duration and worsens its prognosis	11
Verbal and spatial memory spans in mild cognitive impairment	10
Initial cognitive impairment predicts shorter survival of patients with glioblastoma	10
Effects of fast‐velocity concentric resistance training in people with multiple sclerosis: A randomized controlled trial	10
Online psychological interventions to improve symptoms in multiple sclerosis: A systematic review	10
Lifestyle and complementary therapies in multiple sclerosis guidelines: Systematic review	10
Greater occipital nerve block for chronic migraine patients: A meta‐analysis	10
Prevalence and affective correlates of subjective cognitive decline in patients with de novo Parkinson's disease	10
Epilepsy in adult patients with tuberous sclerosis complex	10
Plasma total tau predicts executive dysfunction in Parkinson's disease	10
Repeated infusion of autologous adipose tissue‐derived stem cells for Parkinson's disease	10
Proinflammatory protein signatures in cryptogenic and large artery atherosclerosis stroke	10
Functional outcome and quality of life after meningioma surgery: a systematic review	10
Association of consciousness impairment and mortality in people with COVID‐19	10
Effects of transdermal nicotine delivery on cognitive outcomes: A meta‐analysis	9
Seizure detection based on wearable devices: A review of device, mechanism, and algorithm	9
Basal IL‐6 and S100b levels are associated with infarct volume	9
Seizure freedom and plasma levels of newer generation antiseizure medications	9
Swedish guidelines for device‐aided therapies in Parkinson's disease —Economic evaluation and implementation	9
Optical coherence tomography in patients with Wilson's disease	9
Onset of efficacy and adverse events during Cenobamate titration period	9
Cerebrospinal fluid cytokines and metalloproteinases in cerebral amyloid angiopathy‐related inflammation	9
Non‐convulsive seizures and non‐convulsive status epilepticus in neuro‐intensive care unit	9
Treatment satisfaction with calcitonin gene‐related peptide monoclonal antibodies as a new patient‐reported outcome measure: A real‐life experience in migraine	9
Help‐seeking behaviour and subsequent patient and system delays in stroke	9
Electrodiagnostic findings in patients with non‐COVID‐19‐ and COVID‐19‐related acute respiratory distress syndrome	9
Definition of drug‐resistant epilepsy: A reappraisal based on epilepsy types	9
Birth characteristics and risk of febrile seizures	9
Cannabis use in Parkinson’s disease—A nationwide online survey study	8
S100B and neuron‐specific enolase levels in episodic and chronic migraine	8
Impaired neck motor control in chronic whiplash and tension‐type headache	8
Caffeinated drinks, fruit juices, and epilepsy: A systematic review	8
Genetic analysis reveals novel variants for vascular cognitive impairment	8
Fluid biomarkers in stroke: From animal models to clinical care	8
Deep brain stimulation of the subthalamic nucleus for epilepsy	8
In vivo microstructural white matter changes in early spinocerebellar ataxia 2	8
EEG spindles integrity in critical care adults. Analysis of a randomized trial	8
Theory of mind: A clue for the interpretation of functional movement disorders	8
End‐of‐life care in amyotrophic lateral sclerosis: A comparative registry study	8
Association between irritable bowel syndrome and Parkinson's disease: A systematic review and meta‐analysis	8
Brain networks in patients with isolated or recurrent transient global amnesia	8
Withdrawal failure in patients with chronic migraine and medication overuse headache	8
Efficacy and safety of fenfluramine in patients with Dravet syndrome: A meta‐analysis	8
Effects of robotic rehabilitation on recovery of hand functions in acute stroke: A preliminary randomized controlled study	8
Stroke admissions and revascularization treatments in Denmark during COVID‐19	8
Neurological side effects of COVID‐19 vaccines are rare	8
Adverse effects of levodopa/carbidopa intrajejunal gel treatment: A single‐center long‐term follow‐up study	8
Prevalence and development of idiopathic normal pressure hydrocephalus: A 16‐year longitudinal study in Japan	8
Potential mechanism of SARS‐CoV ‐2‐associated central and peripheral nervous system impairment	8
Poststroke epilepsy incidence, risk factors and treatment: German claims analysis	8
Central vein sign: A putative diagnostic marker for multiple sclerosis	7
STN‐DBS affects language processing differentially in Parkinson's disease: Multiple‐case MEG study	7
Retinal changes associated with multivitamin deficiency before and after supplementation	7
The Prehospital Stroke Score and telephone conference: A prospective validation	7
40‐Hz auditory stimulation for intracranial interictal activity: A pilot study	7
Difficulties in the prehospital assessment of patients with TIA/stroke	7
Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes	7
Response to first antiseizure medication in patients diagnosed with epilepsy	7
Epidemiology of status epilepticus in a non‐urban area in Switzerland	7
Surgery in intractable epilepsy—physicians' recommendations and patients' decisions	7
The impact of COVID‐19 in Dravet syndrome: A UK survey	7
Identification of focal epilepsy by diffusion tensor imaging using machine learning	7
Increased level of LIGHT/TNFSF14 is associated with survival in aneurysmal subarachnoid hemorrhage	7
Systemic thrombolysis in ischaemic stroke patients with COVID‐19	7
Acute stroke care during the first phase of COVID‐19 pandemic in Norway	7
Cognitive change after DBS in refractory epilepsy: A randomized‐controlled trial	7
Early post‐traumatic seizures in hospitalized patients with traumatic brain injury	7
Sonographic pattern of median nerve enlargement in Hansen's neuropathy	7
Eslicarbazepine acetate response in intellectual disability population versus general population	7
Genotype‐phenotype analysis of MT‐ATP6 ‐associated Leigh syndrome	7
Cortical remodeling before and after successful temporal lobe epilepsy surgery	6
Levetiracetam as first‐line monotherapy for Idiopathic Generalized Epilepsy in women	6
Quality of life and resource utilization‐Swedish data from the Care of Late‐Stage Parkinsonism (CLaSP) study	6
Topiramate, acupuncture, and BoNT‐A for chronic migraine: a network meta‐analysis	6
Relapse factors of patients of anti‐N‐methyl‐D‐aspartate receptor encephalitis	6
Fetal posterior cerebral artery configurations in an ischemic stroke versus an unselected hospital population	6
Changes in epilepsy causes of death: A US population study	6
Ultrasound pattern of anterolateral leg muscles in facioscapulohumeral muscular dystrophy	6
Presenting symptoms and functional outcome of chronic subdural hematoma patients	6
Epilepsy in the time of COVID‐19	6

Positron emission tomography in autoimmune encephalitis: Clinical implications and future directions	6
Narcolepsy treatment in Sweden: An observational study	6
Epilepsy care and COVID‐19: A cross‐sectional online survey from Lithuania	6
Validating the diagnosis of multiple sclerosis using Swedish administrative data in Värmland County	6
Sports and trauma as risk factors for Motor Neurone Disease: New Zealand case–control study	6
Teleneurology in Parkinson's disease: A step‐by‐step video guide	6
Minor hallucinations in isolated rapid eye movement sleep behavior disorder indicative of early phenoconversion: A preliminary study	6
Changing epidemiology of traumatic brain injury among the working‐aged in Finland: Admissions and neurosurgical operations	6
Perceived and actual changes in gait balance after CSF shunting in idiopathic normal pressure hydrocephalus	6
Abnormal blood oxygen level‐dependent fluctuations and remote connectivity in sleep‐related hypermotor epilepsy	5
Reasons and predictors of non‐thrombolysis in patients with acute ischemic stroke admitted within 4.5 h	5
Epileptic seizure control during and after pregnancy in Australian women	5
Acute‐onset binocular diplopia in neurological unit: Aetiological factors and diagnostic assessment	5
Fatigue prevalence and associated factors in patients with multiple system atrophy	5
Identification of a pre‐possible multiple system atrophy phase	5
Treatment of occipital neuralgia using onabotulinum toxin A	5
Valproic acid and socioeconomic associations in Swedish women with epilepsy 2010–2015	5
Does continuous electroencephalography influence therapeutic decisions in neurocritical care?	5
Stroke after COVID‐19 vaccination	5
Efficacy and safety of cenobamate in patients with uncontrolled focal seizures: A meta‐analysis	5
Diplopia in Parkinson's disease: Indication of a cortical phenotype with cognitive dysfunction?	5
Direct economic burden of patients with tuberculous meningitis in western China	5
Paediatric sudden unexpected death in epilepsy: A parental report cohort	5
Clinical significance of bilateral epileptiform discharges in temporal lobe epilepsy	5
Corticosteroids in patients with vestibular neuritis: An updated meta‐analysis	5
Eptinezumab for migraine prevention in patients 50 years or older	5
Long‐term outcomes after aneurysmal subarachnoid hemorrhage: A prospective observational cohort study	5
Medium‐term changes in patients with epilepsy during the COVID‐19 pandemic	5
Interictal brain activity changes in temporal lobe epilepsy: A quantitative electroencephalogram analysis	5
Reconsidering the role of selective sodium channel blockers in genetic generalized epilepsy	5
Impact of ictal subtraction SPECT and PET in presurgical evaluation	5
Ischemic stroke in oral anticoagulated patients with atrial fibrillation	5
Complementary and alternative medicine for treating epilepsy in China: A systematic review	5
Valproic acid use in fertile women with genetic generalized epilepsies	5
Pathophysiology of transient neurological deficit in patients with chronic subdural hematoma: A systematic review	5
Validation of Spanish version of 15‐item myasthenia gravis quality‐of‐life questionnaire	4
Six generations of CHMP2B ‐mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survival	4
Interest in and exposure to headache disorders among neurology residents in Denmark: A nationwide cross‐sectional survey	4
Miller Fisher syndrome following COVID ‐19 vaccines: A scoping review	4
Four Swedish cases of CSF1R‐related leukoencephalopathy: Visualization of clinical phenotypes	4
Long‐term effects of zonisamide in adult patients with intellectual disability	4
Antiplatelet therapy increases symptomatic ICH risk after thrombolysis and thrombectomy	4
Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines	4
Epilepsy syndromes in Iran: A systematic review	4
The CHA2DS2‐VASc risk score predicts successful endovascular treatment in patients with acute ischemic stroke	4
Dopamine transporter SPECT imaging in corticobasal syndrome: A peak into the underlying pathology?	4
Myasthenia gravis—treatment and severity in nationwide cohort	4
Balance and physical functioning in Spinocerebellar ataxias 3 and 10	4
Thrombectomy in large vessel occlusion stroke—Does age matter?	4
Prehospital identification of large vessel occlusion using the FAST‐ED score	4
Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE‐PD observational study	4
Thrombolysis for stroke in elderly in the late window period	4
Epidemiological profile of myasthenia gravis in South Korea using the national health insurance database	4
An Exploratory Study of Cognitive Involvement in Hereditary Transthyretin Amyloidosis	4
Clinical features and spectrum of NOTCH3 variants in Finnish patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CA	4
Natural history of circulating miRNAs in Duchenne disease: Association with muscle injury and metabolic parameters	4
Risk factor control after ischemic stroke or transient ischemic attack	3
Memory outcomes of temporal lobe surgery in adults aged over 45 years	3
Trends in pediatric epilepsy surgery: A lower‐middle‐income country perspective	3
Predictors of mortality for acute vertebrobasilar artery occlusion receiving endovascular treatment	3
Role of tumor necrosis factor‐alpha in the pathophysiology of idiopathic intracranial hypertension	3
Prehospital triage optimization of patients with large vessel occlusion by Austrian Prehospital Stroke Scale	3
Serum Markers of Neuronal Damage and Astrocyte Activity in Patients with Chronic Epilepsy: Elevated Levels of Glial Fibrillary Acidic Protein	3
Brain and nerves affected before the lungs in COVID‐19	3
Characteristics of sagittal spinopelvic alignment in patients with Parkinson's disease	3
Progress of clinical research studies on tuberous sclerosis complex‐related epilepsy in China	3
Is there a role for off‐label high‐efficacy disease‐modifying drugs in progressive multiple sclerosis? A network meta‐analysis	3
Impaired procedural memory in narcolepsy type 1	3
Comorbidities in patients with Unverricht–Lundborg disease ( EPM1 )	3
Natural history and remarkable psychiatric state of late‐onset amyotrophic lateral sclerosis in China	3
Cotinine levels influence the risk of rupture of brain aneurysms	3
Immunological, Clinical, and Epidemiological Features of Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection	3
Progress in pathogenesis and therapy of Rasmussen's encephalitis	3
Ethical issues in stroke thrombolysis revisited	3
Pain localization in cluster headache patients: Onset, peak, and radiation	3
Prognosis and Outcome of Cerebral Sinus Venous Thrombosis—A Multicenter Cohort Study	3
Collateral circulation detected by arterial spin labeling predicts outcome in acute ischemic stroke	3
Characteristics of cerebral sinus venous thrombosis in men	3
The impact of a Danish stroke campaign: A cross‐sectional study	3
Comparison of large vessel occlusion scales using prehospital patient reports	3
Overactive bladder in patients with myasthenia gravis—A cross‐sectional population‐based study	3
Thrombolysis in acute ischaemic stroke patients with chronic kidney disease	3
The efficiency of mirror therapy on drop foot in Multiple Sclerosis Patients	3
Tocilizumab for severe refractory primary central nervous system vasculitis: A center experience	3
Is infarct core growth linear? Infarct volume estimation by computed tomography perfusion imaging	3